תוצאות בדיקת זרע +שאלות על טיפול

מציאות הנוגדנים אינה פגעת ישירות בזרע, אך מורה על סיכון מוגבר להדבקה בכלמידיה. יתכן והרופא ימליץ על טיפול אנטיביוטי לך ולאשתך. ההמלצה האם להמשיך לקיים יחסי מין עם אשתך מותנה מתי התרחשה ההדבקה, כלומר האם נחשפת לארחונה לאפשרות של הדבקה מבת זוג אחרת, או שממילא סביר שלא מדובר בהדבקה שהתרחשה לאחרונה. IgA antibodies to Chlamydia trachomatis AND seminal parameters in asymptomatic infertile males. Arch Androl. 2001 May-Jun;46(3):189-95. Penna Videau S, Cermeno Vivas J, Salazar N. Universidad de Oriente, Escuela de Medicina, Departamento de Ciencias Fisiologicas, Ciudad Bolivar, Venezuela. Prevalence of IgA antibodies to Chlamydia trachomatis in semen samples from infertile men was estimated AND its clinical meaning is discussed. The ejaculate of 102 infertile men without any symptom of genital infection was studied, AND seminal alterations were classified according to WHO criteria. Antichlamydial IgA antibodies were detected using a solid-phase, enzyme-linked immunoassay (ImmunoComb II Chlamydia trachomatis monovalent IgA) AND related to sperm count, motility AND membrane integrity, seminal leucocyte count, AND past history of sexually transmitted disease (STD). Prevalence of IgA antibodies to C. trachomatis was 23%. There was no relationship between IgA antibodies AND the sperm variables OR leucocyte count in semen. However, a strong association between antichlamydial IgA antibodies AND the antecedent of STD was found (p < .005; OR = 6). IgA antibodies to C. trachomatis did not cause alterations in sperm function AND they were not associated with inflammatory response. However, these antibodies in semen of asymptomatic infertile men would indicate a risk of C. trachomatis infection for the couples of those patients. Antibodies to chlamydia trachomatis in semen AND relationship with parameters of male fertility. Hum Reprod. 1996 Jul;11(7):1408-17. Eggert-Kruse W, Buhlinger-Gopfarth N, Rohr G, Probst S, Aufenanger J, Naher H, Runnebaum B. Department of Gynaecological Endocrinology AND Reproductive Medicine, Women's Hospital, Heidelberg, Germany. To screen for infection with Chlamydia trachomatis in semen samples from asymptomatic men in couples consulting for infertility AND to determine the relationship of seminal chlamydial antibodies with clinically relevant parameters of male fertility, 197 randomly chosen patients were enrolled in a prospective study. The median duration of infertility was 4 years (range 1-18). Screening for C. trachomatis AND chlamydial antibodies of the immunoglobulin (Ig) A AND IgG classes were performed in ejaculates and, in parallel, endocervical material from the partners of the patients AND serum samples from both partners were evaluated. A comprehensive examination of semen quality included sperm analyses, semen cultures, local antisperm antibody (ASA) testing, the determination of potential infection markers, AND sperm-cervical mucus interaction testing in vitro (SCMPT) AND in vivo (post-coital testing). Chlamydial IgA antibodies were found in the semen samples of 18.8% (37/197) of the patients, while chlamydial IgG antibodies were found in 8.1% (16/197) of the patients. Screening for C. trachomatis was negative in all semen AND cervical specimens. Only 5.5% of men remembered a past genital infection. Chlamydia antibodies (IgA/Ig/G) in semen were significantly correlated with chlamydia IgG antibodies in serum samples (P < 0.001). No marked relationship was found between the presence of seminal chlamydial antibodies AND the major parameters of sperm analysis, semen cultures, local ASA AND sperm penetration testing as an indicator of functional capacity. Seminal chlamydial antibodies were not significantly associated with potential infection OR inflammation markers in aliquots of the same ejaculates. However, a significant relationship of chlamydial antibodies in patients' semen with past genital infections of their female partners was found with clinical relevance for a tubal infertility factor. The results indicate that in asymptomatic patients the presence of chlamydial antibody IgA OR IgG in semen is not associated with reduced semen quality, potential seminal infection markers OR impaired functional capacity as important determinants of male fertility; however, seminal chlamydial antibodies suggesting a previous sexually transmitted disease are significantly related to a tubal infertility factor of female partners.